Market Place
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations. 
X
Please Wait
Applying Filters...
01 Dr. Reddy's Laboratories (11)
02 NanoAlvand (2)
03 ABEX Pharmaceutica (2)
04 Accord healthcare (12)
05 Accure Labs (2)
06 Actavis Inc (3)
07 Adven Pharma (Pty) Ltd (2)
08 Apotex Inc (4)
09 AqVida GmbH (4)
10 Auro Pharma Inc (2)
11 Biocon (2)
12 CinnaGen Co (2)
13 Cipla Medpro South Africa (1)
14 DR REDDY'S LABORATORIES LTD (2)
15 Eagle Pharmaceuticals (1)
16 Eli Lilly (10)
17 Eriochem S.A. (2)
18 Flagship Biotech International Pvt. Ltd (2)
19 Forrester Pharma (1)
20 Fresenius Kabi Oncology Limited (2)
21 GetWell Pharmaceutical (2)
22 Health Biotech (2)
23 Hospira, Inc. (2)
24 InterPharma (6)
25 Jodas Expoim Pvt. Ltd (2)
26 Kiara Health (2)
27 Naprod Life Sciences (2)
28 Nishchay Pharmaceuticals Pvt. Ltd. (2)
29 ORIFARM GROUP AS (2)
30 Panacea Biotec Limited (2)
31 SEACROSS PHARMACEUTICALS (2)
32 Samyang Biopharmaceuticals (3)
33 Sandoz B2B (2)
34 Sun Pharmaceutical Industries Limited (6)
35 Taro Pharmaceutical Industries (3)
36 Teva Pharmaceutical Industries (5)
37 TherDose Pharma (2)
38 Vinkem Labs Ltd (1)
39 With bits of (1)
40 Yangtze River Pharmaceutical Group (2)
01 FREEZE-DRIED POWDER (2)
02 INJ (1)
03 INJECTABLE; INJECTION (1)
04 INJECTABLE;INJECTION (7)
05 INJECTION (5)
06 Infusion (5)
07 Injectable (2)
08 Injection (14)
09 LYOPHILIZED INJECTION (1)
10 LYOPHILIZED POWDER (4)
11 Liquid Injection (1)
12 Lyo.Inj (2)
13 Lyophilised Injection (2)
14 Lyophilized Injection (3)
15 POI (8)
16 POR (4)
17 POWDER FOR SOLUTION (10)
18 Pemeterxed 100Mg 1 Unit Parenteral Use (1)
19 Pemeterxed 500Mg 1 Unit Parenteral Use (1)
20 Powder For Solution For Infusion (2)
21 Powder for Solution for Infusion (2)
22 Powder to concentrate to the infusion fluid, resolution (14)
23 SOLUTION;INTRAVENOUS (4)
24 Vial (4)
25 Blank (20)
01 Generic (23)
02 Generic Dossier Available (4)
03 Lead Market Dossiers- Filed (3)
04 Lead Market Dossiers- TentativenApproved in US (3)
05 Lead Market Dossiers-TentativenApproved in US and Approved in EU (2)
06 Originator (2)
07 Prescription (10)
08 RX (4)
09 Blank (69)
01 ALIMTA (2)
02 Alimta (7)
03 Alimta 100 mg (1)
04 Alvopem (4)
05 EXTREDA 100 (1)
06 EXTREDA 500 (1)
07 MARTXEL (2)
08 Naxate 100 (1)
09 Naxate 500 (1)
10 PEMED S (3)
11 PEMETED (2)
12 PEMETRA (2)
13 PEMETREXED (7)
14 PEMETREXED DISODIUM FOR INJECTION (4)
15 PEMETREXED FOR INJECTION (3)
16 PEMETREXED FOR INJECTION, USP (2)
17 PEMFEXY (1)
18 PEXALI 100 (1)
19 PEXALI 500 (1)
20 Pemetrexed APOTEX (2)
21 Pemetrexed Accord (9)
22 Pemetrexed Accord 100 (1)
23 Pemetrexed Accord 500 (1)
24 Pemetrexed Cipla 500 (1)
25 Pemetrexed Ever Pharma (6)
26 Pemetrexed Fresenius Kabi (2)
27 Pemetrexed Hospira (2)
28 Pemetrexed SUN (6)
29 Pemetrexed Sandoz (2)
30 Pemetrexed with bits of (1)
31 Pemject (1)
32 Pemtori IV 100mg (1)
33 Pemtori IV 500mg (1)
34 TARO-PEMETREXED (3)
35 Terexta 500 (1)
36 Blank (34)
01 Argentina (2)
02 Australia (20)
03 Canada (10)
04 China (2)
05 Germany (4)
06 India (27)
07 Iran (4)
08 Italy (2)
09 Norway (14)
10 South Africa (13)
11 South Korea (3)
12 Switzerland (5)
13 USA (12)
14 United Kingdom (2)
